The start-up of new HSCT centers in low-middle income countries (LMIC) has received little attention, due to a lack of local resources and expertise,1 despite a high frequency of malignant… Click to show full abstract
The start-up of new HSCT centers in low-middle income countries (LMIC) has received little attention, due to a lack of local resources and expertise,1 despite a high frequency of malignant and non-malignant conditions, such as thalassemia and sickle cell disease, requiring transplantation. As a result, many patients are forced to go abroad when a transplant is needed, with major problems for their families and the governments.
               
Click one of the above tabs to view related content.